{
    "name": "gadoteridol",
    "comment": "Rx",
    "other_names": [
        "ProHance"
    ],
    "classes": [
        "Gadolinium-Containing Contrast Agents"
    ],
    "source": "https://reference.medscape.com/drug/prohance-gadoteridol-343767",
    "pregnancy": {
        "common": [
            "GBCAs cross the placenta and result in fetal exposure and gadolinium retention",
            "Human data on the association between GBCAs and adverse fetal outcomes are limited and inconclusive",
            "Estimated background risk of major birth defects and miscarriage for the indicated population is unknown",
            "All pregnancies have a background risk of birth defect, loss, or other adverse outcomes"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "In animal reproduction studies in rats, drug doubled the incidence of post-implantation loss at up to 16 times recommended human dose (RHD); there were no adverse developmental effects observed in rabbits with intravenous administration of gadoteridol during organogenesis at doses up to 19 times the recommended human dose of 0.1 mmol/kg"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "There are no data on presence of drug in human milk, effects on breastfed infant, or on milk production; however, published lactation data on other GBCAs indicate that 0.01 to 0.04% of maternal gadolinium dose is present in breast milk and there is limited GBCA gastrointestinal absorption in breast-fed infant; drug is present in rat milk",
            "Developmental and health benefits of breastfeeding should be considered together with the mother’s clinical need for the drug and any potential adverse effects on the breastfed infant or from underlying maternal condition"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [
                "Risk for nephrogenic systemic fibrosis (NSF) with acute or chronic renal insufficiency (GFR <30 mL/min/1.73 sq.m, hepatorenal syndrome, or acute renal insufficiency resulting from perioperative liver transplant",
                "NSF affects internal organs, skin, and muscle and can be fatal",
                "Only use if essential and MRI cannot not provide appropriate diagnostic image",
                "Screen for renal dysfunction, do not exceed recommended dosage, and allow for drug elimination before giving subsequent doses"
            ],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Caution in hyperthyroidism, pheochromocytoma, renal/hepatic impairment",
                "Therapy in patients with sickle cell anemia not studied",
                "Screen patients for kidney disease before use and monitor renal function afterward; nephrogenic systemic fibrosis (NSF) associated with use of gadolinium contrast media in patients with kidney disease; do not exceed recommended dose (see Black Box Warnings)"
            ],
            "specific": [
                {
                    "type": "Gadolinium retention",
                    "description": [
                        "Gadolinium is retained for months or years in several organs",
                        "Highest concentrations (nanomoles per gram of tissue) have been identified in the bone, followed by other organs (eg, brain, skin, kidney, liver, and spleen)",
                        "Duration of retention also varies by tissue and is longest in bone",
                        "Patients requiring multiple lifetime doses, pregnant and pediatric patients, and patients with inflammatory conditions are at higher risk of gadolinium retention",
                        "Brain deposits",
                        "FDA investigated the risk of brain deposits following repeated use of GBCAs for MRI in 2015",
                        "Publications in the medical literature have reported that deposits of GBCAs remain in the brains of some patients who undergo ≥4 contrast MRI scans, long after the last administration",
                        "As of 2017, the FDA review had not identified adverse health effects from gadolinium retained in the brain after the use of GBCAs MRI; all GBCAs may be associated with some gadolinium retention in the brain and other body tissues",
                        "Early data in rat studies show that linear GBCAs are more prone to dissociation into free gadolinium and demonstrate greater brain deposition than macrocyclic GBCAs, which are less prone to dissociation"
                    ]
                },
                {
                    "type": "Hypersensitivity reactions",
                    "description": [
                        "Anaphylactic and anaphylactoid reactions reported, involving cardiovascular, respiratory, and/or cutaneous manifestations",
                        "Some patients experienced circulatory collapse and died; in most cases, initial symptoms occurred within minutes of administration and resolved with prompt emergency treatment",
                        "Prior to administration, ensure availability of trained personnel and medications to treat hypersensitivity reactions",
                        "Consider risk for hypersensitivity reactions, especially in patients with a history of hypersensitivity reactions or a history of asthma or other allergic disorders; if such a reaction occurs, stop drug and immediately begin appropriate therapy",
                        "Observe patients for signs and symptoms of a hypersensitivity reaction during and for up to 2 hours after therapy administration"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "General disorders and administration site conditions",
            "percent": null
        },
        {
            "name": "Asthenia",
            "percent": null
        },
        {
            "name": "chest discomfort",
            "percent": null
        },
        {
            "name": "facial edema",
            "percent": null
        },
        {
            "name": "feeling hot",
            "percent": null
        },
        {
            "name": "injection site coldness",
            "percent": null
        },
        {
            "name": "injection site erythema",
            "percent": null
        },
        {
            "name": "injection site pain",
            "percent": null
        },
        {
            "name": "injection site warmth",
            "percent": null
        },
        {
            "name": "pain",
            "percent": null
        },
        {
            "name": "pyrexia",
            "percent": null
        },
        {
            "name": "Cardiac",
            "percent": null
        },
        {
            "name": "Angina pectoris",
            "percent": null
        },
        {
            "name": "palpitations",
            "percent": null
        },
        {
            "name": "atrioventricular block first degree",
            "percent": null
        },
        {
            "name": "Ear and labyrinth disorders",
            "percent": null
        },
        {
            "name": "Ear discomfort",
            "percent": null
        },
        {
            "name": "tinnitus",
            "percent": null
        },
        {
            "name": "Eye disorders",
            "percent": null
        },
        {
            "name": "Eye pruritus",
            "percent": null
        },
        {
            "name": "lacrimation increased",
            "percent": null
        },
        {
            "name": "Gastrointestinal disorders",
            "percent": null
        },
        {
            "name": "Abdominal discomfort",
            "percent": null
        },
        {
            "name": "abdominal pain",
            "percent": null
        },
        {
            "name": "diarrhea",
            "percent": null
        },
        {
            "name": "dry mouth",
            "percent": null
        },
        {
            "name": "gingival pain",
            "percent": null
        },
        {
            "name": "oral pruritus",
            "percent": null
        },
        {
            "name": "swollen tongue",
            "percent": null
        },
        {
            "name": "vomiting",
            "percent": null
        },
        {
            "name": "Infections and infestations",
            "percent": null
        },
        {
            "name": "Gingivitis",
            "percent": null
        },
        {
            "name": "rhinitis",
            "percent": null
        },
        {
            "name": "Investigations",
            "percent": null
        },
        {
            "name": "Alanine aminotransferase increased",
            "percent": null
        },
        {
            "name": "aspartate aminotransferase increased",
            "percent": null
        },
        {
            "name": "blood chloride increased",
            "percent": null
        },
        {
            "name": "blood pressure immeasurable",
            "percent": null
        },
        {
            "name": "blood urea decreased",
            "percent": null
        },
        {
            "name": "hemoglobin decreased",
            "percent": null
        },
        {
            "name": "heart rate increased",
            "percent": null
        },
        {
            "name": "Metabolism and nutrition disorders",
            "percent": null
        },
        {
            "name": "Decreased appetite",
            "percent": null
        },
        {
            "name": "hypoglycemia",
            "percent": null
        },
        {
            "name": "Musculoskeletal and connective tissue disorders",
            "percent": null
        },
        {
            "name": "Back pain",
            "percent": null
        },
        {
            "name": "musculoskeletal stiffness",
            "percent": null
        },
        {
            "name": "Nervous system disorders",
            "percent": null
        },
        {
            "name": "Formication",
            "percent": null
        },
        {
            "name": "hypoesthesia",
            "percent": null
        },
        {
            "name": "hypokinesia",
            "percent": null
        },
        {
            "name": "lethargy",
            "percent": null
        },
        {
            "name": "loss of consciousness",
            "percent": null
        },
        {
            "name": "migraine",
            "percent": null
        },
        {
            "name": "paresthesia",
            "percent": null
        },
        {
            "name": "presyncope",
            "percent": null
        },
        {
            "name": "seizure",
            "percent": null
        },
        {
            "name": "syncope",
            "percent": null
        },
        {
            "name": "taste disorder",
            "percent": null
        },
        {
            "name": "Psychiatric disorders",
            "percent": null
        },
        {
            "name": "Anxiety",
            "percent": null
        },
        {
            "name": "mental status changes",
            "percent": null
        },
        {
            "name": "Respiratory",
            "percent": null
        },
        {
            "name": "thoracic",
            "percent": null
        },
        {
            "name": "and mediastinal disorders",
            "percent": null
        },
        {
            "name": "Cough",
            "percent": null
        },
        {
            "name": "dry throat",
            "percent": null
        },
        {
            "name": "dyspnea",
            "percent": null
        },
        {
            "name": "nasal discomfort",
            "percent": null
        },
        {
            "name": "throat irritation",
            "percent": null
        },
        {
            "name": "Skin and subcutaneous tissue disorders",
            "percent": null
        },
        {
            "name": "Hyperhidrosis",
            "percent": null
        },
        {
            "name": "pruritus",
            "percent": null
        },
        {
            "name": "rash",
            "percent": null
        },
        {
            "name": "rash morbilliform",
            "percent": null
        },
        {
            "name": "Vascular disorders",
            "percent": null
        },
        {
            "name": "Flushing",
            "percent": null
        },
        {
            "name": "hypotension",
            "percent": null
        },
        {
            "name": "peripheral coldness",
            "percent": null
        },
        {
            "name": "vascular rupture",
            "percent": null
        },
        {
            "name": "vasodilatation",
            "percent": null
        },
        {
            "name": "vasospasm",
            "percent": null
        }
    ]
}